Literature DB >> 3029405

Murine cells carrying integrated tandem genomes of hepatitis B virus DNA transcribe RNAs from endogenous promoters on both viral strands and express middle and major viral envelope proteins.

A Z Zelent, M A Sells, P M Price, A Mohamad, G Acs, J K Christman.   

Abstract

Clone 4.10 cells were isolated as a methotrexate-resistant clone arising after cotransfection of mouse 3T3 cells with plasmid DNA containing a head-to-tail dimer of the hepatitis B virus (HBV) genome and DNA coding for methotrexate-resistant dihydrofolate reductase. The majority of methotrexate-resistant clones derived by this procedure have been found to contain multiple copies of the HBV genome, but the intact HBV dimer was rarely preserved. In contrast, 4.10 cells contained at least 40 copies of intact HBV dimer per cell. These cells produced large amounts of 22-nm hepatitis B surface antigen particles that included viral envelope proteins reactive with the pre-S2 region-specific antibody, indicating transcription and translation of the pre-S2 and S regions of the integrated viral genomes. The cells also synthesized viral e antigen, which was released into the culture medium. Characterization of polyadenylated viral RNAs transcribed from the long (minus) strand of the integrated HBV DNA demonstrated the presence of shorter-than-genome-length RNAs containing only X region sequences, shorter-than-genome-length RNAs containing both X and S region sequences, and longer-than-genome-length RNAs containing core, X, and S region sequences. Start sites for transcripts were mapped 5' to and within the pre-S region and 5' to and within the precore region at approximately the same sites as those utilized for HBV transcription during viral replication in infected livers. Polyadenylated RNA transcripts complementary to the short (plus) strand of HBV that initiated and terminated within the intact and integrated head-to-tail tandem viral genomes were also detected.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3029405      PMCID: PMC254071          DOI: 10.1128/JVI.61.4.1108-1115.1987

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  43 in total

1.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

2.  Expression of hepatitis B viral core region in mammalian cells.

Authors:  M J Roossinck; S Jameel; S H Loukin; A Siddiqui
Journal:  Mol Cell Biol       Date:  1986-05       Impact factor: 4.272

3.  Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I.

Authors:  P W Rigby; M Dieckmann; C Rhodes; P Berg
Journal:  J Mol Biol       Date:  1977-06-15       Impact factor: 5.469

4.  RNA molecular weight determinations by gel electrophoresis under denaturing conditions, a critical reexamination.

Authors:  H Lehrach; D Diamond; J M Wozney; H Boedtker
Journal:  Biochemistry       Date:  1977-10-18       Impact factor: 3.162

5.  Production of hepatitis B virus by a differentiated human hepatoma cell line after transfection with cloned circular HBV DNA.

Authors:  C Sureau; J L Romet-Lemonne; J I Mullins; M Essex
Journal:  Cell       Date:  1986-10-10       Impact factor: 41.582

6.  The human hepatitis B virus enhancer requires trans-acting cellular factor(s) for activity.

Authors:  S Jameel; A Siddiqui
Journal:  Mol Cell Biol       Date:  1986-02       Impact factor: 4.272

7.  Isolation and partial characterization of three methotrexate-resistant phenotypes from Chinese hamster ovary cells.

Authors:  W F Flintoff; S V Davidson; L Siminovitch
Journal:  Somatic Cell Genet       Date:  1976-05

8.  Purification of biologically active globin messenger RNA by chromatography on oligothymidylic acid-cellulose.

Authors:  H Aviv; P Leder
Journal:  Proc Natl Acad Sci U S A       Date:  1972-06       Impact factor: 11.205

9.  Mapping the major transcripts of ground squirrel hepatitis virus: the presumptive template for reverse transcriptase is terminally redundant.

Authors:  G H Enders; D Ganem; H Varmus
Journal:  Cell       Date:  1985-08       Impact factor: 41.582

10.  Transcription of woodchuck hepatitis virus in the chronically infected liver.

Authors:  T Möröy; J Etiemble; C Trépo; P Tiollais; M A Buendia
Journal:  EMBO J       Date:  1985-06       Impact factor: 11.598

View more
  7 in total

1.  XAP2, a novel hepatitis B virus X-associated protein that inhibits X transactivation.

Authors:  N Kuzhandaivelu; Y S Cong; C Inouye; W M Yang; E Seto
Journal:  Nucleic Acids Res       Date:  1996-12-01       Impact factor: 16.971

2.  Properties of the human hepatitis B virus enhancer: position effects and cell-type nonspecificity.

Authors:  J L Vannice; A D Levinson
Journal:  J Virol       Date:  1988-04       Impact factor: 5.103

3.  The hepatitis B virus enhancer modulates transcription of the hepatitis B virus surface antigen gene from an internal location.

Authors:  G A Bulla; A Siddiqui
Journal:  J Virol       Date:  1988-04       Impact factor: 5.103

4.  Replicative intermediate of hepatitis B virus in transfected murine fibroblasts.

Authors:  A Z Zelent; M A Sells; M Shvartsman; P M Price; G Acs
Journal:  J Virol       Date:  1987-09       Impact factor: 5.103

Review 5.  Use of HBsAg quantification in the natural history and treatment of chronic hepatitis B.

Authors:  Lung-Yi Mak; Wai-Kay Seto; James Fung; Man-Fung Yuen
Journal:  Hepatol Int       Date:  2019-11-19       Impact factor: 6.047

6.  Hepatitis B viruses with precore region defects prevail in persistently infected hosts along with seroconversion to the antibody against e antigen.

Authors:  H Okamoto; S Yotsumoto; Y Akahane; T Yamanaka; Y Miyazaki; Y Sugai; F Tsuda; T Tanaka; Y Miyakawa; M Mayumi
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103

7.  Expression of infectious woodchuck hepatitis virus in murine and avian fibroblasts.

Authors:  C Seeger; B Baldwin; B C Tennant
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.